'Breath test' shows promise for diagnosing fungal pneumonia

October 23, 2014, Infectious Diseases Society of America

Many different microbes can cause pneumonia, and treatment may be delayed or off target if doctors cannot tell which bug is the culprit. A novel approach—analyzing a patient's breath for key chemical compounds made by the infecting microbe—may help detect invasive aspergillosis, a fungal infection that is a leading cause of mortality in patients with compromised immune systems, according to a proof-of-concept study now online in Clinical Infectious Diseases.

Currently difficult to diagnose, this type of fungal pneumonia often requires a lung biopsy for definitive identification. For debilitated patients with , including organ or bone marrow transplant recipients and patients on chemotherapy, such an invasive procedure may be challenging. A non-invasive method that can also identify the type of fungus causing pneumonia could lead to earlier and more targeted treatment in these cases.

Sophia Koo, MD, of Brigham and Women's Hospital in Boston, and a team of researchers wondered if they could find a unique "chemical signature" in the breath of patients being evaluated for fungal pneumonia. In the lab, they identified several compounds, or metabolites, normally produced by Aspergillus fumigatus and other fungi that can cause pneumonia.

The researchers then analyzed breath samples from 64 patients with suspected cases of invasive aspergillosis and assessed whether it was possible to distinguish patients with this fungal pneumonia from patients who did not have this illness. Based on the identification of these fungal compounds in the , they identified patients with the with high accuracy—94 percent sensitivity and 93 percent specificity. (In other words, the method was able to detect 94 percent of patients who actually had or likely had the disease, and misidentified as infected 7 percent of patients who were not actually infected.)

There were no adverse events related to the breath collection procedure, the authors reported. It was well-tolerated, including by patients who had difficulty breathing or required supplemental oxygen.

"Identification of the underlying microbial etiology remains elusive in most patients with pneumonia, even with invasive diagnostic measures," Dr. Koo said. "Our findings provide proof-of-concept that we can harness detection of species-specific metabolites to identify the precise microbial cause of pneumonia, which may guide appropriate treatment of these infections."

More research will be needed to validate the findings and refine the approach before it can be considered for clinical use, the authors noted. If supported by future research, the method also may have applications in other kinds of pneumonia. "We can likely also use this volatile metabolite profiling approach to identify other, more common causes of pneumonia," Dr. Koo said.

Fast Facts:

  • Invasive aspergillosis is a cause of fungal pneumonia that is difficult to diagnose, and it is a leading cause of mortality in immune-compromised patients.
  • Researchers were able to detect key compounds, or metabolites, produced by Aspergillus fungi in the breath of patients with fungal pneumonia.
  • Using this approach, researchers correctly distinguished with invasive aspergillosis from those who did not have the illness.

Explore further: New antifungal as effective as existing drugs with fewer adverse events

Related Stories

New antifungal as effective as existing drugs with fewer adverse events

September 7, 2014
A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the ...

Study examines postoperative pneumonia prevention program in surgical ward

July 23, 2014
A postoperative pneumonia prevention program for patients in the surgical ward at a California Veterans Affairs hospital lowered the case rate for the condition, which can cause significant complications and increase the ...

Team finds method for more precise diagnosis of pneumonia

September 23, 2014
A patient survives life-threatening trauma, is intubated in the intensive care unit (ICU) to support his or her affected vital functions, starts to recover, and then develops pneumonia. It's a scenario well-known to physicians, ...

Researchers identify tests to diagnose invasive aspergillosis with 100 percent accuracy

August 13, 2014
The fungal infection invasive aspergillosis (IA) can be life threatening, especially in patients whose immune systems are weakened by chemotherapy or immunosuppressive drugs. Despite the critical need for early detection, ...

GP judgement not enough to accurately diagnose cases of pneumonia

January 23, 2013
Pneumonia cannot be accurately diagnosed solely on a doctor's analysis of symptoms and patient history, according to new findings.

Randomized trial examines community-acquired pneumonia treatments

October 6, 2014
In a randomized clinical trial of antibiotic treatments for community-acquired pneumonia (CAP), researchers did not find that monotherapy with β-lactam alone was worse than a combination therapy with a macrolide in patients ...

Recommended for you

Research finds new mechanism that can cause the spread of deadly infection

April 20, 2018
Scientists at the University of Birmingham have discovered a unique mechanism that drives the spread of a deadly infection.

Selection of a pyrethroid metabolic enzyme CYP9K1 by malaria control activities

April 20, 2018
Researchers from LSTM, with partners from a number of international institutions, have shown the rapid selection of a novel P450 enzyme leading to insecticide resistance in a major malaria vector.

Study predicts 2018 flu vaccine will have 20 percent efficacy

April 19, 2018
A Rice University study predicts that this fall's flu vaccine—a new H3N2 formulation for the first time since 2015—will likely have the same reduced efficacy against the dominant circulating strain of influenza A as the ...

Low-cost anti-hookworm drug boosts female farmers' physical fitness

April 19, 2018
Impoverished female farm workers infected with intestinal parasites known as hookworms saw significant improvements in physical fitness when they were treated with a low-cost deworming drug. The benefits were seen even in ...

Zika presents hot spots in brains of chicken embryos

April 19, 2018
Zika prefers certain "hot spots" in the brains of chicken embryos, offering insight into how brain development is affected by the virus.

Super-superbug clones invade Gulf States

April 18, 2018
A new wave of highly antibiotic resistant superbugs has been found in the Middle East Gulf States, discovered by University of Queensland researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.